Suven Life Sciences an ISO 9001, ISO 14001 and OHSAS 18001 company has received United States Food and Drugs Administration (US FDA) acceptance for its facility in Pashamylaram, near Hyderabad. The company has undergone US FDA renewal inspection at their facility in Pashamylaram for the manufacture and supply of active pharmaceutical ingredients (bulk drugs), ntermediates and formulations under cGMP.
Based on the inspection and the review thereafter US-FDA has classified Suven facility at Pashamylaram as acceptable for manufacture and supply of active pharmaceutical ingredients, intermediates and formulations. So far Suven Life Sciences has filed 29 DMF’s and 1 ANDA from this facility which is FDA complaint under cGMP and continued after renewal inspection.
Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.
Based on the inspection and the review thereafter US-FDA has classified Suven facility at Pashamylaram as acceptable for manufacture and supply of active pharmaceutical ingredients, intermediates and formulations. So far Suven Life Sciences has filed 29 DMF’s and 1 ANDA from this facility which is FDA complaint under cGMP and continued after renewal inspection.
Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.
No comments:
Post a Comment